All News #Library
Rare Diseases
Mirum Pharma Acquires Bluejay to Boost Rare Disease Leadership
26 Jan 2026 //
BUSINESSWIRE
Mirum Pharma Enters into Definitive Agreement to Acquire Bluejay
08 Dec 2025 //
PHARMIWEB
Bluejay Gets EMA Orphan Opinion For BJT-778 In Chronic Hepatitis D
29 May 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support